Patrick Forde
MB BCh
Professor of Oncology, Director Thoracic Oncology Clinical Research
👥Biography 个人简介
Patrick Forde led the CheckMate-816 trial establishing neoadjuvant nivolumab plus chemotherapy as a new standard for resectable NSCLC. His work demonstrated pathologic complete response rates of roughly 24 percent and improved event-free survival versus chemotherapy alone. He directs thoracic oncology clinical research at Johns Hopkins.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Patrick Forde 的研究动态
Follow Patrick Forde's research updates
留下邮箱，当我们发布与 Patrick Forde（Johns Hopkins Sidney Kimmel Comprehensive Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment